First-in-human study of ACT-541468, a novel dual orexin receptor antagonist: characterization of its pharmacokinetics, pharmacodynamics, safety, and tolerability

Author(s):
Muehlan, C.; Juif, P.E.; Gerven, J. van; Heuberger, J.; Dingemanse, J.
Published
2017
Publication type
Article / Letter to editor
Date issued
2017-02-28
Language
English
Is part of
Clinical Pharmacology & Therapeutics (2017), Vol. 101, no. S1, p. S80-S80
hdl
1887/4253987